For those with severe deficiencies, higher doses may be required initially to replenish B12 levels
Patients eligible to enter the trial were 50 years of age or older and had established, stable, CV, cerebrovascular, peripheral artery disease, CKD or NYHA class II and III heart failure or were 60 years of age or older and had other specified risk factors for CV disease
[1] [6] Understanding tirzepatide's mechanism and approved uses provides important context when evaluating potential side effects, including psychological symptoms
Microglia in RP retinas, including in this model, exhibit significant alterations
However, the differences are subtle , and the risk appears to depend more on the amount and speed of weight loss than on the specific drug used
Telogen effluvium or sudden hair loss differs from other forms of hair loss in significant ways